Literatur
Hersh EM, O’Day SJ, Powderly J et al (2010) A phase II multicenter study of ipilimumb with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma. Invest New Drugs [Epub ahead of print]
Hodi FS, Steven J, O’Day SJ et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711–723
Lawrence D, Hamid O, McDermott D et al (2010) Phase II trial of ipilimumab monotherapy in melanoma patients with brain metastasis. ASCO Annual Meeting 2010, Abstract 8523
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ring, J., Hein, R. & Nitschmann, S. Monoklonale Antikörper für die Therapie des metastasierten Melanoms. Internist 52, 902–903 (2011). https://doi.org/10.1007/s00108-011-2885-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-011-2885-5